医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ZTE Signs Cooperation Agreements With Dutch TNO and the Economic Development Board of Almere to Enable Smart City Solutions

2015年01月08日 PM06:48
このエントリーをはてなブックマークに追加


 

AMSTERDAM & SHENZHEN, China

ZTE Corporation (“ZTE”) (H share stock code: 0763.HK / A share stock code: 000063.SZ), a publicly-listed global provider of telecommunications equipment, network solutions and mobile devices, has announced that ZTE Health, a member of the world wide acting ZTE Group, has signed two Memorandums of Understanding: one with the Netherlands Organisation for applied scientific research (TNO) and the other one with the Economic Development Board of Almere (EDBA).

The partners agreed to cooperate in the fields of eHealth and creating a smart city to enable improvements and benefits for the residents of both the city of Almere and the metropolitan area of Amsterdam. As a market-leading provider of smart society solutions, ZTE is becoming increasingly successful in providing first-class ICT technologies to European governments and enterprises.

“We are delighted to start a cooperation and bridge cultures on a mutual important topic like healthcare and jointly manage and improve the ever growing cost of services in both European and Chinese markets,” explained He Shiyou, President of ZTE Health and Executive Vice President of ZTE Corporation. “Our Mission is to use the advantages of information technology and cloud service to increase the efficiency of the healthcare industry and meet the high level and personalised requirements of mass consumers. We make use of the Dutch and the Chinese context by combining the best of information and healthcare technologies with the spirit of Chinese medicine. This is a fully new approach which will lead to the enhancement of the quality of life for all residents.”

The collaborations between ZTE, TNO and EDBA are dedicated to establishing a cloud-based health platform. It will join and merge with the already existing platform used in the Almere Health-Lab and will consist of a comprehensive range of healthcare and preventive services, a big data platform and terminal devices. Health society services include rehabilitative and daily care, home health advisory security, monitoring solutions and elderly real estate projects, which will be combined with an educational module on Chinese preventative medicine, with the aim to not only deliver services to sick and elderly people, but also to raise awareness of preventive health care, a key part of Chinese medicine. Integrated interfaces and visualisation tools will be part of the platform as well as a health community dashboard.

As part of the new MICT (Mobile Information and Communication Technologies) strategy, ZTE established ZTE Health Co. Ltd, a high-tech joint venture between ZTE Group and Homing healthcare, headquartered in Shanghai. Its aim is to apply and commercialise ZTE’s eHealth and mHealth platforms for the European market and to offer customers and their families the highest possible quality of life.

About ZTE

ZTE is a provider of advanced telecommunications systems, mobile devices, and enterprise technology solutions to consumers, carriers, companies and public sector customers. As part of ZTE’s M-ICT strategy, the company is committed to providing customers with integrated end-to-end innovations to deliver excellence and value as the telecommunications and information technology sectors converge. Listed in the stock exchanges of Hong Kong and Shenzhen (H share stock code: 0763.HK / A share stock code: 000063.SZ), ZTE’s products and services are sold to over 500 operators in more than 160 countries. ZTE commits 10 per cent of its annual revenue to research and development and has leadership roles in international standard-setting organizations. ZTE is committed to corporate social responsibility and is a member of the UN Global Compact. For more information, please visit www.zte.com.cn.

CONTACT

ZTE Corporation
Margrete Ma, +86 755 26775207
ma.gaili@zte.com.cn
or
Edelman
PR
Mark Lee, +852 2837 4756
mark.lee@edelman.com
Andres
Vejarano, +852 2837 4735
andres.vejarano@edelman.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent